Eton Pharmaceuticals Inc
NASDAQ:ETON

Watchlist Manager
Eton Pharmaceuticals Inc Logo
Eton Pharmaceuticals Inc
NASDAQ:ETON
Watchlist
Price: 10.445 USD -1.46%
Market Cap: 269.9m USD
Have any thoughts about
Eton Pharmaceuticals Inc?
Write Note

Relative Value

The Relative Value of one ETON stock under the Base Case scenario is 6.891 USD. Compared to the current market price of 10.445 USD, Eton Pharmaceuticals Inc is Overvalued by 34%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ETON Relative Value
Base Case
6.891 USD
Overvaluation 34%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
44
vs Industry
42
Median 3Y
3.9
Median 5Y
5.7
Industry
2.6
Forward
7.1
vs History
vs Industry
3
Median 3Y
-11.6
Median 5Y
-7.9
Industry
23
Forward
-58.4
vs History
0
vs Industry
27
Median 3Y
13.3
Median 5Y
-7
Industry
17.8
vs History
vs Industry
5
Median 3Y
-6.6
Median 5Y
-8.5
Industry
25.4
vs History
9
vs Industry
12
Median 3Y
6.5
Median 5Y
7.6
Industry
2.2
vs History
42
vs Industry
48
Median 3Y
3.3
Median 5Y
4.6
Industry
2.8
Forward
6.7
vs History
9
vs Industry
57
Median 3Y
4.6
Median 5Y
4.4
Industry
5.4
vs History
vs Industry
7
Median 3Y
-12.4
Median 5Y
-8.7
Industry
13.7
Forward
-107.4
vs History
vs Industry
2
Median 3Y
-10.4
Median 5Y
-7.6
Industry
17.2
Forward
-68.2
vs History
0
vs Industry
32
Median 3Y
10.8
Median 5Y
-6.4
Industry
16.5
vs History
vs Industry
19
Median 3Y
-6.3
Median 5Y
-7.4
Industry
19.3
vs History
42
vs Industry
15
Median 3Y
11
Median 5Y
13.4
Industry
2

Multiples Across Competitors

ETON Competitors Multiples
Eton Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Eton Pharmaceuticals Inc
NASDAQ:ETON
269.6m USD 8.6 -40.2 -47.7 -40.1
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
758.2B USD 18.5 90.9 48.9 54.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
367.6B USD 4.2 25 12.1 15.8
US
Merck & Co Inc
NYSE:MRK
250.1B USD 4 20.6 10.4 12.5
CH
Roche Holding AG
SIX:ROG
208.5B CHF 3.6 18.2 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP 4.1 31.3 169.3 253.7
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6
P/E Multiple
Earnings Growth
US
Eton Pharmaceuticals Inc
NASDAQ:ETON
Average P/E: 33.4
Negative Multiple: -40.2
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
90.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25
-22%
US
Merck & Co Inc
NYSE:MRK
20.6
7 336%
CH
Roche Holding AG
SIX:ROG
18.2
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.3
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -53 N/A

See Also

Discover More
Back to Top